Elizabeth Ashlynn FalconerSenior AssociateNelson MullinsWebsitewww.nelsonmullins.comOrganization ProfileFull ProfileConnectEmail404-322-6265 Professional Biography Elizabeth focuses her practice in the areas of pharmaceutical and medical device defense, commercial litigation, transportation, and product liability. More Legal and Business Bylines From Elizabeth Ashlynn Falconer FDA Publishes Paper Detailing Actions It Intends to Take Regarding the Uses of AI Across the Medical Product Life Cycle - (Posted On Thursday, March 21, 2024) Current Legal Analysis Approaching Secondaries Financing from All Angles: Key Considerations for Debt in LP-Led and GP-Led Secondary Transactions by: Cameron A. Roper , Paul Tannenbaum District Court Dismisses Class Action Seeking Wilderness Therapy Benefits by: Sydney L. Juliano , Jennifer Rigterink LDTs: FDA Rolls Out a Phased Implementation for New Regulatory Requirements by: Jessa Boubker , Kyle Y. Faget Why Is The DFPI Requesting Funding To Implement Venture Capital Funding Reporting Mandate? by: Keith Paul Bishop As the (Customs and Trade) World Turns: May 2024 by: Angela M. Santos , Antonio J. Rivera Upcoming Legal Education Events Jun 12 2024 REACH 30/30 - June 12th, 2024 Jun 4 2024 FinTech and Securities Trading Platforms May 29 2024 Emerging Legal Concepts for Generative AI - Part 3 May 22 2024 Integrating Trending AI and CMMC Compliance Into Vendor Management Print